Naproxen Norfri

Naproxen, the active ingredient in Naproxen Norfri, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It is employed to relieve pain, reduce inflammation, and lower fever in adult patients with various musculoskeletal and inflammatory conditions.

GNH USA supplies Naproxen Norfri as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that acts on inflammatory pathways to manage several common conditions. - Pain: provides analgesic relief for mild to moderate acute pain. - Inflammation: reduces swelling associated with arthritis and soft‑tissue injuries. - Fever: lowers elevated body temperature in febrile states. - Musculoskeletal disorders: improves function and comfort in osteoarthritis, rheumatoid arthritis and related disorders.

Adverse reactions may occur with naproxen use and are categorised by frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate tension‑type headache. - Dizziness: transient light‑headedness, especially on standing.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: may present as black stools or vomiting blood. - Cardiovascular events: increased risk of myocardial infarction or stroke, particularly with long‑term use. - Renal impairment: reduced kidney function manifesting as decreased urine output or elevated creatinine.

Before initiating therapy, consider the following safety measures. - Cardiovascular risk: assess history of heart disease or stroke before use. - Gastrointestinal history: avoid in patients with active ulcer disease or recent GI bleeding. - Renal function: monitor kidney parameters in patients with pre‑existing renal impairment. - Concomitant drugs: review use of anticoagulants, other NSAIDs, or corticosteroids for additive risk. - Pregnancy and lactation: use only if clearly indicated after professional evaluation. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Naproxen may interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - Lithium: increased lithium serum concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: possible reduction in renal function. - Methotrexate: decreased clearance leading to toxicity. - SSRIs or SNRIs: elevated risk of upper GI bleeding.